"Smart pillboxes" trial in USA to improve treatment compliance

15 April 2007

The US state of Tennessee's Medicare program has announced a project involving 270 senior citizens to improve treatment compliance and reduce hospitalizations caused by errors. The Med-eMonitor is a system that allows monitoring of patients' health, including blood sugar levels, issues warning reminders for patients to take medications and alerts health carers if the wrong dose or drug is taken.

The company manufacturing the $60 per month system, Informedix, told the Tennessean newspaper that studies show that over 90% compliance rates are achieved with the Med-eMonitor, compared with 40%-50% for non-users. Separate reports in the journals Drugs & Aging and Cancer recorded patients using drugs as directed in only about 50% of cases, with at least 20% quitting chronic disease treatments altogether within a year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight